Microbot Medical praises new AMA radiation policy; cites 92% cut with LIBERTY robot

Microbot Medical Inc.

AMA adopted new policy in late 2025 to strengthen protections from ionizing radiation; Microbot commends the move.
LIBERTY system demonstrated 92% relative reduction in radiation exposure in ACCESS-PVI Study.
LIBERTY is FDA-cleared, single-use, remotely operated, designed for precise navigation with reduced radiation.
Limited Market Release began late 2025; Full Market Release planned for April 2026 at SIR conference.
CEO Harel Gadot says LIBERTY can address staffing shortages and improve care for patients and providers.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.